LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation
1 February 2024
|
ISS, retinal, artificial, LambdaVision, industry, innovation, retinitis pigmentosa, RP
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...
